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Abstract
Background: Participation at the recommended intervals is critical for screening to be effective in reducing
colorectal cancer (CRC) incidence. This study describes patterns of screening participation over four rounds of
fecal immunochemical testing (FIT) to identify whether demographic variables and prior screening satisfaction are
significantly associated with patterns of re-participation.
Methods: Baseline surveys were mailed to 4000 South Australians randomly selected from the electoral-roll.
Respondents (n = 1928/48.2%) were offered four annual FIT rounds. Screening participation and satisfaction at
each round were recorded.
Results: Study participation was 58.5, 66.9, 73.1 and 71.4% respectively over four rounds. Three participation
patterns were described: consistent participation (43.1%), consistent non-participation (26.4%) and inconsistent
participation (changeable; 30.5%), including intermittent and sustained change patterns. Sustained change described
those who changed participatory behavior and then maintained for at least two rounds (n = 375/19.5%). Older people,
and those not working were most likely to sustain participation. Younger invitees, especially men, were more likely to
change participatory behavior and sustain the change. People with higher disadvantage, less education, not working
and with no prior (pre-trial) screening experience were more likely to start participating and drop out. People
dissatisfied with a prior screening test, including finding aspects embarrassing or unpleasant, were also more
likely not to participate in annual screening or to drop out.
Conclusions: The findings identify those at risk of non- or inconsistent participation in rescreening. They should
aid targeting of interventions for demographic groups at risk and ensuring screening experiences are not perceived as
unpleasant or difficult.
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Background
Participation at recommended intervals in fecal-occult
blood test-(FOBT)-based population screening for colo-
rectal cancer (CRC), by either guaiac (gFOBT) or immu-
nochemical FOBT (i.e., fecal immunochemical test
[FIT]) is associated with decreased population mortality
[1–3]. For screening to work effectively to reduce popu-
lation CRC burden, participation patterns should con-
form to evidence-based screening intervals. In Australia,
guidelines recommend an interval of at least once every
2 years for average-risk people aged 50–75 [4] whereas
the USA recommendation is annually after turning 50
[5]. The evidence base supports annual screening [1].
Despite the evidence, participation and re-participation
rates are sub-optimal in Australia and many other coun-
tries [6, 7]. Identifying demographic and other variables
associated with participation, and particularly consistency
in re-participation, would enable the identification of
population subgroups that might benefit from additional
support to screen, or events that might trigger withdrawal
from re-screening, and help in the development of tar-
geted interventions to improve outcomes.
Different cancer screening participation patterns have
been described [8]: people who adhere to all screening
offers (consistent participants); never participate (con-
sistent non-participants); or participate inconsistently
(intermittent/changeable). The latter includes those who
respond to subsequent offers after rejecting the first (late
entrants), those who participate initially but then “drop-
out” and those who screen sporadically. Testing whether
these different patterns of inconsistency are behaviorally
meaningful (i.e., reflect an underlying difference in atti-
tude to, or perception of, screening) is important to as-
sist in identifying strategies to optimize CRC prevention.
Some limited research has been undertaken investigat-
ing participants in cancer screening who “drop-out” of
programs. This group has been contrasted with consist-
ent participants and non-participants because they rep-
resent people who make a behavioral choice that is not
sustained but may be amenable to change. For example,
a study investigating participatory behavior over two
rounds of mammography screening [9] found that
women aged below 50 years who self-reported having a
limiting long term illness were significantly more likely
to be inconsistent screeners. In previous studies investi-
gating CRC rescreening over three rounds, inconsistent
screening was associated with a negative prior screening
experience [10, 11], as well as being younger, male, having
reduced self-efficacy for screening, and lower perceived
health practitioner support [11]. Non-participation in
screening has also been associated with test type and fecal
aversion [11–14]. In one study [14], normalising the fecal
testing process by discussing it in a social setting led to
subsequent participation in screening (‘late entrant’
participation). However, an analysis of only three rounds
of participation is not sufficient to ascertain if changes are
sustained over future rounds.
The extent of consistency in participation that repre-
sents a meaningful commitment to screening for CRC
also remains to be determined. Clearly, there may be
short-term reasons for non-participation; acute ill-health,
postage failure, travel, or significant life challenges. The
clearest indication of a problematic pattern of re-
participation is where a previously consistent screener be-
comes a consistent non-screener. Understanding such a
sustained change might identify previously unknown bar-
riers. Conversely, lessons can also be learned from success;
identifying reasons for sustained change from previous
non-participation to re-participation might provide infor-
mation as to how to engage people in screening and sus-
tain optimal behavior.
We aim to extend Lo et al. [10] and our own earlier
findings [11] by exploring patterns of participation
across four annual rounds of FIT screening provided to
an Australian sample of the general population, and to
identify factors associated with participation over time.
Methods
Study population
As described elsewhere [11], a random sample of 4000
South Australian men and women aged 50–74 was
drawn from the Australian Electoral Roll.
Study design
The study consisted of an initial Baseline survey and a
subsequent screening phase (offered to those who com-
pleted the Baseline survey) conducted annually for 4
years. The Baseline survey is described elsewhere [15].
Round 1 screening invitations were mailed to those
who completed the Baseline survey from the Bowel
Health Service at Repatriation General Hospital Daw
Park between November 2008 and February 2009. Invi-
tees received a screening invitation letter, 2 OC-Sensor
sample tubes (Eiken Chemical Co., Japan), an instruction
brochure, a participant details and consent form, a
screening status form, a short survey regarding aspects
of their screening experience, and a reply-paid envelope.
Subsequently, similar invitations were mailed in the
last quarter of each year 2009–2011. With each invita-
tion, participants received a survey to record screening
experiences and satisfaction with the screening process.
General satisfaction was measured with two items (satis-
faction with the screening service and satisfaction with
their decision) using a five-point Likert scale (1 = Very
Satisfied to 5 = Very Unsatisfied). Participants also rated
their positive (worthwhile, convenient, reassuring, easy
to complete) and negative (embarrassing, unpleasant)
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screening experiences on a Likert scale (1 = Strongly
Agree to 5 = Strongly Disagree).
All survey participants were mailed the four screening
invitations irrespective of participation in prior screening
rounds unless excluded from future FIT offers because
they requested to opt out, or because they reported that
they had completed investigations that precluded the
need for further screening offers.
Participation in any round was defined as returning
the two fecal samples from that round’s offer at any time
between the day after they were sent the screening offer
and kit until the day they were sent the next offer and kit.
Participation was coded as Yes or No. After four screening
offers, 16 different behavioral response patterns were pos-
sible. These will be described in the Results section.
Analyses
Screening participation per round and longitudinally
over rounds were described via frequency distributions,
and Chi-Square analyses examined univariate differences
between invitees in different participation categories.
Differences between reported positive and negative expe-
riences and subsequent screening behavior were investi-
gated with t-test analyses. Binary logistic regression was
used to determine whether initial or recent experiences
had more impact on subsequent screening. Statistical
Package for the Social Sciences (SPSS,v.19) was used.
Results
Survey-respondent characteristics
Baseline surveys were returned by 1928/4000 respon-
dents (48.2%). Survey-respondents were 52.5% female
(n = 1013), aged 50–75 (M = 60.32, SD = 6.60), and
most were married (n = 1487, 77%). About half (50.7%,
n = 953) were currently in the workforce (full or part-
time) and unemployment was low (n = 56, 3%); other
participants were retired or home carers. Most reported
at least secondary school completion (n = 1238, 64.2%),
and 50.2% of these had completed higher education. The
majority (n = 1349, 70.0%) were born in Australia and
spoke English at home (n = 1628, 84.4%); for others, the
mean number of years in Australia was 40.69
(SD = 12.21). Only 20.5% (n = 395) reported no private
health insurance, 18.2% (n = 350) reported a family his-
tory of CRC, which is slightly higher than the familial
population rate of 10–15% reported by Kerber and col-
leagues in 2005 [16].
Measuring relative socio-economic disadvantage
based on post-code [17] showed low levels of disadvan-
tage among participants with the index ranging from
756 to 1124 (M = 997.98,SD = 68.017), a range repre-
sentative of 97% of the wider South Australian popula-
tion as determined by the 2006 Census [18].
Participation in each of the four rounds
Figure 1 is a Consort diagram showing the four-round
screening pathway with study attrition. Participation at
each round was 58.6% (1128/1928), 66.9% (1122/1677),
73% (1133/1550) and 71.4% (1061/1487) respectively.
Most survey-respondents returned kits in at least one
round (n = 1445, 74.9%); 1217 (63.1%) participated in at
least two rounds, 1014 (52.6%) participated in at least
three and 762 (39.5%) participated in all four rounds.
Nearly 40 % (39.5%: 762/1928) of the survey-respondents
participated in all four annual rounds (IN). A further 35.5%
(685/1928) had an inconsistent participation pattern
(CHANGE), and the remaining 24.9% (481/1928) did not
participate in any of the four rounds (OUT). Figure 2 de-
picts the possible participatory behavior patterns. The
number of participants in each classification category is
also shown in Fig. 2. Each classification category is named
for easy future reference, and participation patterns in each
category described.
Demographic associations with participation patterns
Table 1 presents the significant results of chi-square
analyses. Comparisons between those who always par-
ticipated (IN) and those who never did (OUT), showed
IN respondents were more likely to be female, older
(55–74), not working, and with prior (pre-study) FIT
experience. When comparing IN with those who chan-
ged participation (CHANGE), the IN respondents were
more likely to be married and also more likely to be
older (55–74), not working and with prior FOBT ex-
perience. Comparing the CHANGE participants with
those who never participated (OUT) showed the latter
to be more likely to have no prior FOBT experience.
Closer examination of the CHANGE group (comparing
subsets of participatory behavior within the CHANGE
group) showed that, where change in participation was
sustained (CS, n = 375) rather than intermittent (CI,
n = 310), the CS group was older (55–74), and male. Fur-
ther exploration of the sustained change (Cs) participation
pattern was done by comparing this group to those with a
seemingly committed position, IN or OUT. When com-
pared to those in the IN pattern, those who changed par-
ticipation and sustained it (Cs) were more likely to be
younger and male. When compared to the OUT group,
the Cs group were more likely to be older and have some
prior (pre-trial) FIT experience. Comparing consistently
IN with CSIO (those in the Sustained Change category
who changed from In to Out at any point after the first
offer) revealed that those who dropped out were more
likely to be male, younger (50–54), with higher economic
disadvantage and no prior FIT experience. Conversely,
when comparing consistently OUT with CSOI (those in
the Sustained Change category who changed from Out to
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4000 sent Baseline Survey
2054 Non-Responders
1946 Returned completed survey
18 Opted out of FIT offers
1928 therefore eligible for FIT offers (Round 1)




1677 Eligible for FIT Offers (Round 2)




1550 Eligible for FIT Offers (Round 3)




1487 Eligible for FIT Offers (Round 4)

























OUT to IN 
(CSOI)g
(n=182)
Fig. 2 Participatory behavior category flow chart. Participation patterns: aYYYY; bYNNN, NYYY, YYNN, NNYY, NYNN, YNYY, NNYN, YYNY, NYYN,
YNNY, NYNY, YNYN, YYYN, NNNY; cNNNN; dNYNN, YNYY, NNYN, YYNY,NYNY, YNYN, NYYN, YNNY, YYYN, NNNY; eYNNN, NYYY, YYNN, NNYY; fYNNN,
YYNN; gNYYY, NNYY
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Table 1 Significant univariate differences in demographics between different participatory categorisations
Demographic Study FIT Participation Pattern n (%) ChiSquare





Males 579 (46.6) 338 (44.4) 241 (50.1) χ2(1) = 3.686,
p = .055a
Females 664 (53.4) 424 (55.6) 240 (49.9)
Total 1243 (100) 762 (100) 481 (100)
Age
50–54 292 (23.5) 128 (16.8) 164 (34.1) χ2(2) = 55.081,
p < .001**
55–64 607 (48.8) 387 (50.8) 220 (45.7)
65–74 344 (27.7) 247 (32.4) 97 (20.2)
Total 1243 (100) 762 (100) 481 (100)
Employment Status
Not in Workforce 622 (51.2) 409 (54.8) 213 (45.4) χ2(1) = 9.681,
p = .002*
In Workforce 594 (48.8) 338 (45.2) 256 (54.6)
Total 1216 (100) 747 (100) 469 (100)
Baseline Survey
No prior FOBT experience 622 (51.0) 342 (45.6) 280 (59.6) χ2(1) = 22.023,
p < .001**
Prior FOBT experience 598 (49.0) 408 (54.4) 190 (40.4)
Total 1220 (100) 750 (100) 470 (100)





Unmarried 308 (21.5) 147 (19.4) 161 (23.8) χ2(1) = 3.728,
p = .053a
Married/DeFacto 1125 (78.5) 609 (80.6) 516 (76.2)
Total 1433 (100) 756 (100) 677 (100)
Age
50–54 321 (22.2) 128 (16.8) 193 (28.2) χ2(2) = 30.255,
p < .001**
55–64 713 (49.3) 387 (50.8) 326 (47.6)
65–74 413 (28.5) 247 (32.4) 166 (24.2)
Total 1447 (100) 762 (100) 685 (100)
Employment Status
Not in Workforce 714 (50.6) 409 (54.8) 305 (45.9) χ2(1) = 10.587,
p = .001**
In Workforce 697 (49.4) 338 (45.2) 359 (54.1)
Total 1411 (100) 747 (100) 664 (100)
Baseline Survey
No prior FOBT experience 687 (48.4) 342 (45.6) 345 (51.6) χ2(1) = 4.809,
p = .028*
Prior FOBT experience 732 (51.6) 408 (54.4) 324 (48.4)
Total 1419 (100) 750 (100) 669 (100)
Total: CHANGE &
OUT
Changeable (CHANGE) Sustained Non-Participation
(OUT)
Baseline Survey
No prior FOBT experience 625 (54.9) 345 (51.6) 280 (59.6) χ2(1) = 6.824,
p = 0.009*
Prior FOBT experience 514 (45.1) 324 (48.4) 190 (40.4)
Total 1139 (100) 669 (100) 470 (100)
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Table 1 Significant univariate differences in demographics between different participatory categorisations (Continued)





Males 538 (47.3) 338 (44.4) 200 (53.3) χ2(1) = 7.767,
p = .005*
Females 599 (52.7) 424 (55.6) 175 (46.7)
Total 1137 (100) 762 (100) 375 (100)
Age
50–54 232 (20.4) 128 (16.8) 104 (27.7) χ2(2) = 18.526,
p < 001**
55–64 551 (48.5) 387 (50.8) 164 (43.7)
65–74 354 (31.1) 247 (32.4) 107 (28.5)
Total 1137 (100) 762 (100) 375 (100)





50–54 268 (31.3) 164 (34.1) 104 (27.7) χ2(2) = 9.103,
p = .011*
55–64 384 (44.9) 220 (45.7) 164 (43.7)
65–74 204 (23.8) 97 (20.2) 107 (28.5)
Total 856 (100) 481 (100) 375 (100)
Baseline Survey
No prior FOBT experience 460 (55.2) 280 (59.6) 180 (49.5) χ2(1) = 8.096,
p = .004*
Prior FOBT experience 374 (44.8) 190 (40.4) 184 (50.5)
Total 834 (100) 470 (100) 364 (100)





Males 336 (49.1) 136 (43.9) 200 (53.3) χ2(1) = 5.707,
p = .017*
Females 349 (50.9) 174 (56.1) 175 (46.7)
Total 685 (100) 310 (100) 375 (100)
Age
50–54 193 (28.2) 89 (28.7) 104 (27.7) χ2(2) = 8.970,
p = .011*
55–64 326 (47.6) 162 (52.3) 164 (43.7)
65–74 166 (24.2) 59 (19.0) 107 (28.5)
Total 685 (100) 310 (100) 375 (100)
Total: IN & CSIO Sustained Participation
(IN)
Sustained Change
(in to out) (CSIO)
Gender
Males 440 (46.1) 338 (44.4) 102 (52.8) χ2(1) = 4.135,
p = .042*
Females 515 (53.9) 424 (55.6) 91 (47.2)
955 (100) 762 (100) 193 (100)
Age
50–54 182 (19.1) 128 (16.8) 54 (28.0) χ2(2) = 14.240,
p < .001**
55–64 463 (48.5) 387 (50.8) 76 (39.4)
65–74 310 (32.5) 247 (32.4) 63 (32.6)
Total 955 (100) 762 (100) 193 (100)
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In at any point after the first offer,), the latter were signifi-
cantly more likely to have prior FIT experience.
Finally, comparing the Sustained Change categories
CSIO (those who dropped out of annual screening) with
CSOI (those who commenced participation after round 1),
the ‘late entrants’ (CSOI) were more likely to be in the
workforce, have lower economic disadvantage, higher edu-
cation, and prior FIT experience than the ‘drop outs’
(CSIO). From these analyses, it appears that prior
experience with FIT is a key factor in determining
whether someone will respond to a re-screening offer.
Prior FIT experience and satisfaction
Prior (pre-trial) FIT experience was explored further to
discern how it influenced the rescreening decision. Al-
most half of the respondents (47.8%: 922/1928) reported
FIT experience prior to the study. Almost all of these
(96.6%: 891/922) completed the optional baseline survey
Table 1 Significant univariate differences in demographics between different participatory categorisations (Continued)
Tertile of Economic Disadvantage
High Disadvantage 206 (21.6) 156 (20.5) 50 (25.9) χ2(2) = 8.432,
p = .015*
Medium Disadvantage 329 (34.5) 253 (33.2) 76 (39.4)
Low Disadvantage 419 (43.9) 352 (46.3) 67 (34.7)
Total 954 (100) 761 (100) 262 (100)
Baseline Survey
No prior FOBT experience 454 (48.5) 342 (45.6) 112 (60.2) χ2(1) = 12.167,
p < .001**
Prior FOBT experience 482 (51.5) 408 (54.4) 74 (39.8)
Total 936 (100) 750 (100) 186 (100)
Total: CSOI & OUT Sustained Change




No prior FOBT experience 348 (53.7) 68 (38.2) 280 (59.6) χ2(1) = 22.8671,
p < .001**
Prior FOBT experience 300 (46.3) 110 (61.8) 190 (40.4)
Total 648(100) 178 (100) 470 (100)
Total: CSIO & CSOI Sustained Change
(in to out) (CSIO)
Sustained Change
(out to in) (CSOI)
Employment Status
Not in Workforce 179 (49.0) 106 (56.7) 73 (41.0) χ2(1) = 8.348,
p = .004*
In Workforce 186 (51.0) 81 (43.3) 105 (59.0)
Total 365 (100) 187 (100) 178 (100)
Tertile of Economic Disadvantage
High Disadvantage 86 (22.9) 50 (25.9) 36 (19.8) χ2(2) = 9.619,
p = .008*
Medium Disadvantage 130 (34.7) 76 (39.4) 54 (29.7)
Low Disadvantage 159 (42.4) 67 (34.7) 92 (50.5)
Total 375 (100) 193 (100) 182 (100)
Education Status
Lower education (completed high
school or lower)
192 (52.6) 110 (59.1) 82 (52.6) χ2(1) = 5.977,
p = .014*
Higher education (>high school) 173 (47.4) 76 (40.9) 97 (54.2)
Total 365 (100) 186 (100) 179 (100)
Baseline Survey
No prior FOBT experience 180 (49.5) 112 (60.2) 68 (38.2) χ2(1) = 16.762,
p < .001**
Prior FOBT experience 184 (50.5) 74 (39.8) 110 (61.8)
Total 364 (100) 186 (100) 178 (100)
*p < .05; **p < .001
atrend towards significance
Osborne et al. BMC Public Health  (2018) 18:81 Page 7 of 11
question measuring satisfaction with prior (pre-study)
screening. Of those who completed the question, 85.7%
(764/891) were either satisfied or very satisfied with the
experience. Comparisons between participation categories
IN and OUT, between IN and CHANGE and between IN
and those who changed from In to Out and sustained this
change (CSIO), revealed significant differences related to
satisfaction with prior screening and report of negative
screening experiences, with those who were more satisfied
with prior FIT experience and who rated their past
experience as less embarrassing and unpleasant more
likely to sustain participation (IN) (see Table 2).
Associations between prior (pre-study) FIT satisfaction
and experiences and participation in subsequent rounds
were also explored (see Table 2). Satisfaction with pre-
study FIT screening from any source was significantly
associated with subsequent participation; participants at
each round reported higher prior FIT satisfaction com-
pared to non-participants. In addition, non-participation
in either Rounds 2 or 3 was associated with negative
Table 2 Significant t-test comparisons of impact of prior FOBT experience and satisfaction on subsequent screening behavior
patterns
Experience variable Behavior group Frequency (n) Mean t-test result
Sustained In (IN) and Sustained Out (OUT)
Prior FOBT satisfaction IN 408 4.38 t (306) = 2.07, p = .040*
OUT 190 4.22
Sustained In (IN) and Change (CHANGE)
Prior FOBT satisfaction IN 408 4.38 t (718) = 3.59, p < 001**
CHANGE 312 4.16
Round 1 Negativeb IN 611 4.55 t (885) = −2.69, p = .007*
CHANGE 276 4.93
Sustained In (IN) and Sustained Change In to Out(CSIO)
Prior FOBT satisfaction IN 408 4.38 t (478) = 2.38, p = .018*
CSIO 72 4.14
Round 1 Negativeb IN 611 4.55 t (761) = −2.72, p = .007*
CSIO 152 5.03
Prior experience and Round 2 participation
Prior FOBT satisfaction Rnd 2 participant 583 4.30 t (908) = 1.72, p = .085 a
Rnd 2 non-participant 327 4.20
Round 1 Negativeb Rnd 2 participant 728 4.56 t (885) = −3.54, p < 001**
Rnd 2 non-participant 159 5.16
Prior experience and Round 3 participation
Prior FOBT satisfaction Rnd 3 participant 597 4.33 t (908) = 3.03, p = .005*
Rnd 3 non-participant 313 4.15
Round 1 Negativeb Rnd 3 participant 708 4.57 t (885) = −3.06, p = .002*
Rnd 3 non-participant 179 5.07
Round 2 Negativeb Rnd 3 participant 766 4.22 t (856) = −2.85, p = .004*
Rnd 3 non-participant 92 4.83
Round 2 General satisfaction Rnd 3 participant 766 9.16 t (856) = 2.83, p = .005*
Rnd 3 non-participant 92 8.76
Prior experience and Round 4 participation
Prior FOBT satisfaction Rnd 4 participant 562 4.33 t (908) = 2.66, p = .008*
Rnd 4 non-participant 348 4.18
Round 3 General satisfaction Rnd 4 participant 906 4.02 t (1027) = −2.42, p = .016*
Rnd 4 non-participant 123 4.39
atrend towards significance
bnegative experiences (summary score of negative experiences – embarrassing and unpleasant)
*p < .05; **p < .001
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experiences (embarrassment and unpleasantness) re-
ported at the previous screening round within the study.
Being generally satisfied with screening Round 2 was as-
sociated with participation in Round 3. Conversely,
Round 4 non-participants rated their general satisfaction
in Round 3 higher than participants.
Binary Logistic Regression analyses were undertaken
to examine whether behavior (participation/non-partici-
pation) at Round 3 was predicted by the most recent or
less recent FIT testing experience. The analysis was
framed using a 2 block-entry method including the sig-
nificant factors identified in the t-test analysis. The first
block consisted of Round 1 negative experiences, and
block 2 consisted of Round 2 negative experiences and
Round 2 general satisfaction. Inclusion required comple-
tion of survey experience questions from both Round 1
and Round 2. This reduced the sample size to 536 par-
ticipants and 47 non-participants. The outcome was
non-participation in Round 3. All predictors analysed
were non-significant. These results suggest that nega-
tive prior FIT experience at any previous FIT test, irre-
spective of its timing, was predictive of behavior at
future FIT rounds.
Discussion
Most previous studies have examined participant CRC
screening behavior over two [7, 8, 19] or three screening
offers [11, 20, 21], with only one recent population-
based, open-cohort study reporting [6] on four rounds.
The current results concur with previous studies’ find-
ings that younger age groups do not participate as read-
ily in re-screening as older people do [6, 11]. Describing
participatory patterns can better help to identify groups
in the population at risk of not-participating at all or
dropping out altogether from re-participation offers so
that targeted interventions can be developed and imple-
mented [8].
Although a strong and consistent finding in the
screening literature is that male gender is a risk factor
for non-compliance at first invitation [22–25], the re-
sults over multiple rounds suggest a possible cross-over
or, at least, parity. In the UK [21], at the first invitation
round, men were less likely to adhere to the second
round compared to women (OR 0.72, p < .001) and men
who did participate were less likely to adhere to the sec-
ond round compared to women (OR 0.93, p < .05).
However, by the third round the difference in consistent
participation was non-significant (OR 0.96). These re-
sults are consistent with our previous finding that, over
three annual rounds of screening, males were more
likely to initially refuse but participate in later rounds
(RR = 1.77, p < .001) [11]. This pattern has been sus-
tained in the fourth round. There was no significant
difference in participation between males and females
(70% males, 72.5% females, (χ2 (1) = .901, p = .343).
In the current study, as with previous research, partici-
patory patterns were identified, and different demographic
and behavioral variables were found to characterize con-
sistent screeners, consistent non-screeners and inconsist-
ent screeners [8, 11, 15]. People who consistently screened
were older, especially women, and those with prior FIT
participation. Results from the current study, similar to
previous studies that have examined rescreening over two
[8] or three [10, 11, 20] rounds, indicated that younger
age (50–54 years), male gender and higher economic
disadvantage emerged as the main risk factors for non-
adherence to screening opportunities (OUT) or Change-
able screening, (particularly to ‘drop out’).
Our results add to this previous research by examining
screening patterns over four annual rounds, linking
this to previous experience and demographics, and en-
abling the exploration of additional patterns within the
‘CHANGE’ category. Gender differences were found
between those who screened intermittently (more
likely to be female) and those who sustained their
change in screening behavior (more likely to be male).
Two additional patterns were identified within the
Sustained Change category that differentiated between
those who started screening and then discontinued
(CSIO), and those who came into screening later and
stayed (CSOI) with the latter being associated with hav-
ing some prior (pre-trial) FIT experience, being in the
workforce, of lower economic disadvantage and higher
education. The ‘drop out’ participation pattern (CSIO)
was observed in people who had not screened before
the trial, had lower education levels and higher un-
employment. The development of specific interven-
tions targeted to subgroups such as these could be
valuable, not only to encourage awareness and screening
uptake in the first instance, but once screened, to encour-
age regular re-screening.
Prior dis-satisfaction with FIT testing was consistently
associated with the likelihood (or not) of re-participating,
similar to our previous results with this population [11,
15]. We previously found [11] that low self-efficacy (low
confidence in one’s ability to do the screening activities)
and low response efficacy (low confidence in the efficacy
of the test itself ) were associated with a non-participatory
behavior pattern, a finding echoed by others [19, 26]. In
addition, other researchers found that taking part in CRC
rescreening would depend on not feeling too inconve-
nienced [27]. Results from the current study add to our
previous findings that a previous negative experience, such
as finding screening to be embarrassing or unpleasant, is
associated with non-participation at any later rescreening
round, even if that negative experience was well in the
past. Other researchers have also demonstrated an
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association between negative prior experiences (embar-
rassment or disgust) and subsequent non-participation in
re-screening for CRC [26] or breast cancer [28, 29].
The results can be viewed as consistent with the con-
clusions from a meta-analysis which established that
past behaviour predicts substantial variance in subse-
quent behaviour [30]. Even though rescreening behav-
iour occurs only infrequently, that is annually or
biannually, its regularity and social endorsement, and as-
sociation with past compliance, suggest that intention to
rescreen (and rescreening itself ) are driven by cognitions
that endorse the behaviour. Moreover, the significant
negative association with previous dis-satisfaction fur-
ther supports the largely planned, rather than habitual,
nature of the behaviour. When developing interventions
to educate people about CRC screening, and to take
them through their first experience, care should be taken
to make the experience as positive as possible to encour-
age screening maintenance.
Future interventions could include investigating the ef-
fect of different biological sample types, other than
faeces, on screening participation and re-participation
patterns. For example, in a recent Australian survey, par-
ticipants overwhelmingly indicated a preference for a
blood sample rather than the usual fecal sample for CRC
screening [31]. In addition, future studies could examine
the mode of screening kit delivery. In a French study [6,
20], ‘compliant’ participants were more likely to have re-
ceived their kits from their health care provider, and ‘oc-
casional’ participants were those more likely to receive
them by post. The role of the healthcare provider in pro-
viding information about, and support for, CRC screening
should not be underestimated [32]. In addition, if health-
care providers are made more aware of the demographic
risk factors associated with lower screening uptake, they
may be better equipped to identify patients at risk of not
following through with screening recommendations, and
who may benefit from additional support, education and
encouragement.
This study was not without limitations. By the fourth
round of screening offers, whether the more recent or
less recent experience had the greater impact on the
Round 4 screening behavior was difficult to test reliably
due to low sample numbers. In the current study we did
not test whether kit return time, test result or prior col-
onoscopy attendance influenced sustained participation
in screening beyond three rounds, and these variables
may be worth investigating in the future because there is
evidence from a recent study that all three variables are
associated with reduced uptake in re-screening [10].
These variables may have influenced participation over
four rounds in the current study; we found Round 3
negative experiences were not significantly associated
with Round 4 non-participation. In contrast, the results
showed that those who were generally satisfied with
their screening in Round 3 were less likely to participate
in Round 4.
Conclusions
The current study describes participation in four FIT
screening rounds within a single cohort. This enables
the development of a taxonomy of screening participa-
tion patterns including different forms of intermittency.
Having greater information about factors associated with
screening behavior provides the potential to identify
demographic subgroups at risk and assist in the develop-
ment of targeted interventions.
Subgroups likely to participate and re-participate in
every rescreening offer are those who are older, female,
not in the workforce and satisfied with a previous screen-
ing experience. People who start to participate in FIT
screening and then change their participation and drop
out (and sustain the change) are more likely to be male,
younger, with lower education and no prior (pre-trial) FIT
experience. In addition, the current study is the first to
collect data about negative and positive FIT testing experi-
ences prior to commencement of the program as well as
at the end of each round of four rounds of offers. Negative
prior experiences were found to be associated with future
non-participation or a change in participation from ‘in to
out’ up to the third, but not fourth, round of screening.
Future interventions should investigate kit return time,
test results and prior colonoscopy attendance as variables
that may impact on the decision to rescreen, and focus on
ensuring that the introduction into FIT screening is as
positive an experience as possible to encourage mainten-
ance in future screening activities.
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